Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.
Cancers (Basel). 2023 Jan 31;15(3):906. doi: 10.3390/cancers15030906.
Cancers (Basel). 2023.
PMID: 36765863
Free PMC article.
Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311).
Chawla SP, Tellez WA, Chomoyan H, Valencia C, Ahari A, Omelchenko N, Makrievski S, Brigham DA, Chua-Alcala V, Quon D, Moradkhani A, Gordon EM.
Chawla SP, et al. Among authors: valencia c.
Front Oncol. 2023 May 10;13:1116937. doi: 10.3389/fonc.2023.1116937. eCollection 2023.
Front Oncol. 2023.
PMID: 37234994
Free PMC article.
Item in Clipboard
Cite
Cite